leisure time -WSS

leisure time

author：explore 2025-10-02 13:13:46 - browse：39

Beam Therapeutics said Thursday morning it would lay off 20% of its staff — or around 100 employees — and pause or reevaluate certain programs as it looks to cut costs.

It’s a notable setback for a gene-editing company that quickly raised over $1 billion in the few years after its co-founder, David Liu, described a new form of CRISPR, called base editing, that allowed researchers to change individual letters of DNA. The biotech hired rapidly, announced its intention to treat a broad range of diseases, and received clearance to start clinical trials in cancer and sickle cell.

Beam, however, has struggled to enroll patients in those trials. Meanwhile, the biotech stock market has stayed cold, including for gene-editing companies, whose technologies raise new regulatory, safety, and reimbursement questions. The pending approval of two gene therapies for sickle cell would also limit the market for Beam’s lead drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Sen. Paul opposes bill to ban Chinese biotechs

knowledge

WSS

First medicine developed to treat MASH expected to be approved soon

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Wearables generate powerful data but its not useful to doctors, yet

The drug industry has found itself all alone in Washington

UnitedHealth quietly bought dozens of outpatient centers

hotspot

leisure time

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Dobbs anniversary: the lost opportunity of abortion as health care

Headspace, Meta partner to launch VR meditation app for Quest

How to save PrEP access — and even expand it

The problem with charging patients to message their doctors

Bright Health sells Medicare Advantage business to Molina

What it’s like to watch children die of measles

Tori Bowie and the unacceptable rates of Black maternal death

In his State of the Union, Biden takes clear aim at 'Big Pharma'

hotspot

Helping hospitals and community health centers plan for resilience

A deep dive into Applied Therapeutics’ data, and questions on Cassava

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Change Healthcare cyberattack prompts Medicare loan program

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Sen. Paul opposes bill to ban Chinese biotechs

hotspot

knowledge

entertainment

hotspot